a group of 12 children with advanced neuroblastoma ( 7 stage iv and 5 stage iii ) , selected by their initial response to chemotherapy with pulsed cyclophosphamide/vincristine/adriamycin ( cva ) , were given consolidation therapy with high-dose melphalan ( 140 mg/m2 ) and then surgical removal of residual disease .
C0027819
neuroblastoma
C0025241
melphalan